The 58th Annual Denver TB Course (Online Series) provides a broad overview of active and latent TB including its epidemiology, transmission, pathogenesis, diagnosis, treatment and management. The purpose of this course is to present this body of knowledge to general internists, epidemiologists, preventative medicine, public health, infectious disease and chest specialists, physician assistants, nurse practitioners, registered nurses and other health care providers who will be responsible for the management and care of patients with tuberculosis.
58th Annual Denver TB Course (Virtual Series)
Thursdays, April 14 - May 19, 2022 | 4:00 - 5:30 pm MT
All live sessions begin at 3:00 pm PT / 4:00 pm MT / 5:00 pm CT / 6:00 pm ET
- Epidemiology of tuberculosis
- Transmission and pathogenesis
- Diagnosis and treatment of tuberculosis including MDR/XDR-TB
- Diagnosis and treatment of latent tuberculosis infection
- Emphasis on vulnerable populations such as pediatric and HIV co-infection
- Interactive Contact Investigation Workshop
- Discuss the epidemiological features which are associated with increased risk for tuberculosis.
- Explain the clinical manifestations of tuberculosis and how they differ in unique patient populations such as pediatrics or HIV co-infection.
- Recognize the tools available for diagnosis of tuberculosis and their differences, advantages, and possible shortcomings.
- Formulate a treatment regimen for a patient with drug susceptible or drug resistant tuberculosis while understanding the pharmacokinetics and potential toxicities of that regimen.
- Discuss the importance and performance of contact investigation among persons exposed to new cases of communicable TB.
The weekly virtual presentations, led by expert faculty, will be recorded and posted after each presentation for registered attendees.
Topics and Speakers:*
- Contact Investigation Workshop: Robert W. Belknap, MD
- Diagnosis of LTBI: Robert W. Belknap, MD
- Epidemiology: Randall Reves, MD, MSc
- Laboratory Services: Reeti Khare, PhD
- Monitoring and Management of Side Effects: Shannon H. Kasperbauer, MD
- Pediatric TB: James T. Gaensbauer, MD, MS
- Radiographic Presentation: Tilman L. Koelsch, MD
- TB and HIV Co-infection: Michelle K. Haas, MD
- Treatment of Drug-Resistant TB: Charles L. Daley, MD
- Treatment of Drug Susceptible TB: David E. Griffith, MD
- Treatment of LTBI: Jared J. Eddy, MD
*Agenda is subject to change.